You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
| Title |
Impact of radiographer immediate reporting of chest X-rays from general practice on the lung cancer pathway (radioX): study protocol for a randomised control trial
|
|---|---|
| Published in |
Trials, November 2017
|
| DOI | 10.1186/s13063-017-2268-x |
| Pubmed ID | |
| Authors |
Nick Woznitza, Anand Devaraj, Samuel M. Janes, Stephen W. Duffy, Angshu Bhowmik, Susan Rowe, Keith Piper, Sue Maughn, David R. Baldwin |
| Abstract |
Diagnostic capacity and suboptimal logistics are consistently identified as barriers to timely diagnosis of cancer, especially lung cancer. Immediate chest X-ray (CXR) reporting for patients referred from general practice is advocated in the National Optimal Lung Cancer Pathway to improve time to diagnosis of lung cancer and to reduce inappropriate urgent respiratory medicine referral for suspected cancer (2WW) referrals. The aim of radioX is to examine the impact of immediate reporting by radiographers of CXRs requested by general practice (GP) on lung cancer patient pathways. A two-way comparative study that will compare the time to diagnosis of lung cancer for patients. Internal comparison will be made between those who receive an immediate radiographer report of a GP CXR compared to standard radiographer GP CXR reporting over a 12-month period. External comparison will be made with a similar, neighbouring hospital trust that does not have radiographer CXR reporting. Primary outcome is the effect on the speed of the lung cancer pathway (diagnosis of cancer or discharge). Secondary outcomes include the effect of the pathway on efficiency including the number of repeat CXRs performed in a timely fashion for suspected infection and the effect of immediate reporting of GP CXRs on patient satisfaction. The radioX trial will examine the hypothesis that immediate reporting of CXRs referred from GP reduces the time to diagnosis of lung cancer or discharge from the lung cancer pathway. International Standard Randomised Controlled Trial Number ISRCTN21818068 . Registered on 20 June 2017. |
X Demographics
The data shown below were collected from the profiles of 33 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 15 | 45% |
| Ireland | 2 | 6% |
| Canada | 2 | 6% |
| Australia | 1 | 3% |
| Chile | 1 | 3% |
| Nigeria | 1 | 3% |
| United States | 1 | 3% |
| Unknown | 10 | 30% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 16 | 48% |
| Scientists | 8 | 24% |
| Practitioners (doctors, other healthcare professionals) | 6 | 18% |
| Science communicators (journalists, bloggers, editors) | 3 | 9% |
Mendeley readers
The data shown below were compiled from readership statistics for 99 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 99 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 19 | 19% |
| Student > Master | 16 | 16% |
| Other | 6 | 6% |
| Researcher | 6 | 6% |
| Lecturer > Senior Lecturer | 5 | 5% |
| Other | 18 | 18% |
| Unknown | 29 | 29% |
| Readers by discipline | Count | As % |
|---|---|---|
| Nursing and Health Professions | 36 | 36% |
| Medicine and Dentistry | 21 | 21% |
| Agricultural and Biological Sciences | 2 | 2% |
| Environmental Science | 1 | 1% |
| Biochemistry, Genetics and Molecular Biology | 1 | 1% |
| Other | 6 | 6% |
| Unknown | 32 | 32% |